REG - OptiBiotix Health - Notice of Results <Origin Href="QuoteRef">OPTIO.L</Origin>

OptiBiotix HealthAnnouncement

15/07/2015 17:20

RNS Number : 9666M
OptiBiotix Health PLC
13 May 2015
13 May 2015
Optibiotix Health Plc
Notice of Results
Analyst Briefing
OptiBiotix Health plc (AIM: OPTI), a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, will announce its results for the year ended 30 November 2014 on Friday 29 May 2015.
A briefing for analysts will take place at Walbrook PR, 4 Lombard Street, London EC3V 9HD at 9.30am on Friday 29 May 2015.
If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or emailoptibiotix@walbrookpr.com.
For further information:
OptiBiotix Health plc
www.optibiotix.com
Stephen O'Hara, Chief Executive
Contact via Walbrook below


Cairn Financial Advisers LLP
Tel: 020 7148 7900
Liam Murray / Avi Robinson



Hybridan LLP (Joint Broker)
Claire Louise Noyce
Tel: 020 3713 4581


Peterhouse Corporate Finance Ltd (Joint Broker)
Tel: 020 7469 0936
Lucy Williams / Duncan Vasey



Walbrook PR Ltd
Tel: 020 7933 8780 or optibiotix@walbrookpr.com
Anna Dunphy
Mob: 07876 741 001
Mike Wort
Mob: 07900 608 002

This information is provided by RNS
The company news service from the London Stock Exchange
  END
NORLLFESEDIFLIE